The Effect of Soy Isoflavones on Non-alcoholic Fatty Liver Disease and the Level of FGF-21 and Fetuin A
NCT06101433
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
46
Enrollment
OTHER
Sponsor class
Conditions
NAFLD
Interventions
DIETARY_SUPPLEMENT:
Soy isoflavone
OTHER:
Placebo
Sponsor
Ahvaz Jundishapur University of Medical Sciences